BioSpace News Archive

Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the 38th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis in San Francisco on Wednesday, January 15, 2020, at 11:00 a.m. Pacific time (2:00 p.m. Eastern time).

PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, announced today that senior management will host institutional investor and partnering meetings at the LifeSci Advisors Corporate Access Event taking place at the Sir Francis Drake Hotel in San Francisco, January 13-15, 2020.

A landmark two-year follow-up study on the Ellipsys® Vascular Access System was highlighted at the annual Controversies in Dialysis Access (CiDA) meeting, one of the premier dialysis access medical conferences in the world.

Developed in collaboration with Mayo Clinic, the algorithm would help healthcare providers detect heart failure during a standard physical exam

Proceeds provide sufficient funds to extend operations and ongoing trials late into the fourth quarter of 2020 Company does not intend to raise additional capital for ninety days following the closing of the offering NEWTOWN, Pa., Dec. 18, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova” or the “Company”), a Phase 3-stage biopharmaceutical company discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes (

Award for Excellence in Human Research Protection for 2019 was announced by Dr. Peter G. Goldschmidt, President and Founder of Health Improvement Institute.

BeyondSpring Inc. (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global biopharmaceutical company focused on the development of innovative cancer therapies, today provided an update on the Company’s operations and announced its financial results for the three months ended September 30, 2019.

Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) and Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) today announced that they have entered into a collaboration to discover, develop and commercialize novel therapies for sickle cell disease (SCD) and beta thalassemia.

The National Council of State Boards of Nursing Board of Directors (NCSBN BOD) voted on Dec. 9, 2019, to raise the passing standard for the NCLEX-PN Examination (the National Council Licensure Examination for Practical Nurses).

Cogitativo, Inc., the first-to-market data-science-as-a-service (DSaaS) company for healthcare service organizations, announced today the closing of an $18.5 million Series B round of financing.